- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Decision Making in R/R MM: What Options to Consider for 1st Relapse in Disease not Refractory to Lenalidomide, First Relapse in Lenalidomide-Refractory Disease, or After 2+ Prior Therapies?
0 views
January 11, 2021
Comments 0
Login to view comments.
Click here to Login
Myeloma